NeuroMolecular Medicine

, Volume 16, Issue 2, pp 517–528 | Cite as

miR-145 Inhibits Migration and Invasion of Glioma Stem Cells by Targeting ABCG2

  • Lei ShiEmail author
  • Zhimin Wang
  • Guan Sun
  • Yi Wan
  • Jun Guo
  • Xingli FuEmail author
Original Paper


Despite advances in clinical therapies and technologies, the prognosis for patients with malignant glioma is poor. Our previous research demonstrated that glioma stem cells (GSCs) were crucial for glioma malignancy and accelerated tumor migration and invasion. The migration and invasion of malignant glioma cells into the surrounding normal brain tissues cause the poor outcome. miR-145, a miRNA found to be expressed in neurons, was recently found to have reduced expression in glioblastoma multiforme tumors. And miR-145 loss in glioma cells led to increased cell proliferation and invasion. However, its function on the migration and invasion of GSCs was still unknown. In this study, we aimed to identify the effects and mechanisms of miR-145 on the migration and invasion of GSCs. Our investigations revealed that miR-145 was low expressed in malignant glioma tissues and their corresponding GSCs. Knockdown of miR-145 in vitro could enhance the migration and invasion of GSCs, while up-regulation of miR-145 had the opposite effects. Further investigation of the potential mechanism demonstrated that the function of miR-145 in regulating the migration and invasion of GSCs is mediated by its targeting of ABCG2 mRNA. ABCG2 is an ATP-binding cassette transporter protein, which was identified to be overexpressed in GSCs and higher-grade glioma tissues. We found that miR-145 was negative correlated with ABCG2 levels in GSCs, and reduction in ABCG2 expression decreased the cell migration and invasion of GSCs. Further, a luciferase reporter proved that ABCG2 was a direct target of miR-145 in GSCs. Thus, these findings underscore the potential of miR-145 to regulate the migration and invasion of GSCs through targeting ABCG2.


miR-145 Migration Invasion Glioma stem cells ABCG2 



This work was supported by the China Natural Science Foundation (81000963, 81370062, and 81302196), Jiangsu Province’s 333 Talent Program (BRA2011046), Jiangsu Province “six personnel peak” funded projects (2013-WSN-028), Jiangsu Province’s Natural Science Foundation (BK2012670), Medical Research Foundation by Jiangsu Province Health Department (YG201301 and Z201318), the Clinical Technology Development of Jiangsu University (JLY20120053), the Kunshan Social Development Foundation (KS1006, KS1009), and the Suzhou Social Development Foundation (SYS201063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest

All authors have declared the sources of research funding for this manuscript and have no financial or other contractual agreements that might cause (or be perceived as causes of) conflicts of interest.


  1. Adammek, M., Greve, B., Kässens, N., Schneider, C., Brüggemann, K., Schüring, A.N., et al. (2013) MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors. Fertility and sterility 99(5), 1346–1355.e5.Google Scholar
  2. Alison, M. R., Islam, S., & Wright, N. A. (2010). Stem cells in cancer: Instigators and propagators? Journal of Cell Science, 123(Pt 14), 2357–2368.PubMedCrossRefGoogle Scholar
  3. Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756–760.PubMedCrossRefGoogle Scholar
  4. Beier, D., Röhrl, S., Pillai, D. R., Schwarz, S., Kunz-Schughart, L. A., Leukel, P., et al. (2008). Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Research, 68(14), 5706–5715.PubMedCrossRefGoogle Scholar
  5. Bhatia, P., Bernier, M., Sanghvi, M., Moaddel, R., Schwarting, R., Ramamoorthy, A., et al. (2012). Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells. Xenobiotica, 42(8), 748–755.PubMedCentralPubMedCrossRefGoogle Scholar
  6. Bise, R., Kanade, T., Yin, Z., & Huh, S. I. (2011). Automatic cell tracking applied to analysis of cell migration in wound healing assay. IEEE Conference Proceedings of Engineering in Medicine Biology Society, 2011, 6174–6179.Google Scholar
  7. Bleau, A. M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., et al. (2009). PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell, 4(3), 226–235.PubMedCentralPubMedCrossRefGoogle Scholar
  8. Campayo, M., Navarro, A., Viñolas, N., Diaz, T., Tejero, R., Gimferrer, J. M., et al. (2013). Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. European Respiratory Journal, 41(5), 1172–1178.PubMedCrossRefGoogle Scholar
  9. Chen, Z., Liu, F., Ren, Q., Zhao, Q., Ren, H., Lu, S., et al. (2010). Suppression of ABCG2 inhibits cancer cell proliferation. International Journal of Cancer, 126(4), 841–851.Google Scholar
  10. Chiou, S. H., Yu, C. C., Huang, C. Y., Lin, S. C., Liu, C. J., Tsai, T. H., et al. (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clinical Cancer Research, 14, 4085–4095.PubMedCrossRefGoogle Scholar
  11. Darling, J. L. (1990). The in vitro biology of human brain tumors. In D. G. T. Thomas (Ed.), Neuro-oncology: Primary malignant brain tumors (pp. 1–25). Baltimore Md: Johns Hopkins University Press.Google Scholar
  12. Fillmore, H. L., VanMeter, T. E., & Broaddus, W. C. (2001). Membrane-type matrix metalloproteinases (MT-MMPs): Expression and function during glioma invasion. Journal of Neuro-oncology, 53(2), 187–202.PubMedCrossRefGoogle Scholar
  13. Haapa-Paananen, S., Chen, P., Hellström, K., Kohonen, P., Hautaniemi, S., Kallioniemi, O., et al. (2013). Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. PLoS One, 8(4), e60930.PubMedCentralPubMedCrossRefGoogle Scholar
  14. Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Research, 67, 4827–4833.PubMedCrossRefGoogle Scholar
  15. Jia, J., Tian, Q., Ling, S., Liu, Y., Yang, S., & Shao, Z. (2013). miR-145 suppresses osteogenic differentiation by targeting Sp7. FEBS Letters, 587(18), 3027–3031.PubMedCrossRefGoogle Scholar
  16. Jin, Y., Bin, Z. Q., Qiang, H., Liang, C., Hua, C., Jun, D., et al. (2009). ABCG2 is related with the grade of glioma and resistance to mitoxantrone, a chemotherapeutic drug for glioma. Journal of Cancer Research and Clinical Oncology, 135(10), 1369–1376.PubMedCrossRefGoogle Scholar
  17. Lee, H. K., Bier, A., Cazacu, S., Finniss, S., Xiang, C., Twito, H., et al. (2013). MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One, 8(2), e54652.PubMedCentralPubMedCrossRefGoogle Scholar
  18. Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120(1), 15–20.PubMedCrossRefGoogle Scholar
  19. Li, W. Q., Li, Y. M., Tao, B. B., Lu, Y. C., Hu, G. H., Liu, H. M., et al. (2010). Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance. Medical Science Monitor, 16(10), HY27–HY30.PubMedGoogle Scholar
  20. Lu, Y., Chopp, M., Zheng, X., Katakowski, M., Buller, B., & Jiang, F. (2013). MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncology Reports, 29(1), 67–72.PubMedCentralPubMedGoogle Scholar
  21. Mohan, A., Kandalam, M., Ramkumar, H. L., Gopal, L., & Krishnakumar, S. (2006). Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma. British Journal of Ophthalmology, 90, 889–893.PubMedCentralPubMedCrossRefGoogle Scholar
  22. Okamoto, A., Chikamatsu, K., Sakakura, K., Hatsushika, K., Takahashi, G., & Masuyama, K. (2009). Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncology, 45, 633–639.PubMedCrossRefGoogle Scholar
  23. Omran, O. M. (2012). The prognostic value of breast cancer resistance protein (BCRB/ABCG2) expression in breast carcinomas. Journal of Environmental Pathology, Toxicology and Oncology, 31(4), 367–376.PubMedCrossRefGoogle Scholar
  24. Pek, J. W., Lim, A. K., & Kai, T. (2009). Drosophila maelstrom ensures proper germline stem cell lineage differentiation by repressing microRNA-7. Developmental Cell, 17, 417–424.PubMedCrossRefGoogle Scholar
  25. Rani, S. B., Rathod, S. S., Karthik, S., Kaur, N., Muzumdar, D., & Shiras, A. S. (2013). MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro Oncology, 15(10), 1302–1316.PubMedCrossRefGoogle Scholar
  26. Shi, L., Wan, Y., Sun, G., Gu, X., Qian, C., Yan, W., et al. (2012). Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells. NeuroMolecular Medicine, 14(4), 303–316.PubMedCrossRefGoogle Scholar
  27. Speranza, M. C., Frattini, V., Pisati, F., Kapetis, D., Porrati, P., Eoli, M., et al. (2012). NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget, 3(7), 723–734.PubMedCentralPubMedGoogle Scholar
  28. Stupp, R., Tonn, J. C., Brada, M., & Pentheroudakis, G. (2010). High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21, v190–v193.PubMedCrossRefGoogle Scholar
  29. Wang, F., Xue, X., Wei, J., An, Y., Yao, J., Cai, H., et al. (2010). hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. British Journal of Cancer, 103(4), 567–574.PubMedCentralPubMedCrossRefGoogle Scholar
  30. Xia, H., Cheung, W. K., Ng, S. S., Jiang, X., Jiang, S., Sze, J., et al. (2012). Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. Journal of Biological Chemistry, 287(13), 9962–9971.PubMedCentralPubMedCrossRefGoogle Scholar
  31. Xiang, L., Su, P., Xia, S., Liu, Z., Wang, Y., Gao, P., et al. (2011). ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma. Diagnostic Pathology, 6, 90.PubMedCentralPubMedCrossRefGoogle Scholar
  32. Xu, Q., Liu, L., Qian, X., Chen, Q., Jiang, Y., Li, D., et al. (2012). MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Research, 40, 761–774.PubMedCentralPubMedCrossRefGoogle Scholar
  33. Xu, Z. Y., Wang, K., Li, X. Q., Chen, S., Deng, J. M., Cheng, Y., et al. (2013). The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells. Ultrasonics, 53(1), 232–238.PubMedCrossRefGoogle Scholar
  34. Yang, S., Cui, H., Xie, N., Icyuz, M., Banerjee, S., Antony, V. B., et al. (2013). miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB Journal, 27(6), 2382–2391.PubMedCrossRefGoogle Scholar
  35. Ye, X. Z., Xu, S. L., Xin, Y. H., Yu, S. C., Ping, Y. F., Chen, L., et al. (2012). Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. Journal of Immunology, 189(1), 444–453.CrossRefGoogle Scholar
  36. Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A. M., Sampath, J., Morris, J. J., et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine, 7(9), 1028–1034.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of NeurosurgeryThe First People’s Hospital of Kunshan Affiliated with Jiangsu UniversitySuzhouPeople’s Republic of China
  2. 2.Department of NeurosurgerySuzhou Kowloon Hospital Affiliated with Shanghai Jiao Tong University School of MedicineSuzhouPeople’s Republic of China
  3. 3.Department of NeurosurgeryFourth Affiliated Yancheng Hospital of Nantong UniversityYanchengPeople’s Republic of China
  4. 4.Jiangsu University Health Science CenterZhenjiangPeople’s Republic of China

Personalised recommendations